News
LFCR
4.200
-2.10%
-0.090
Weekly Report: what happened at LFCR last week (0914-0918)?
Weekly Report · 5d ago
Lifecore Biomedical: A Messy Balance Sheet, A Much Better Business
Seeking Alpha · 09/14 13:59
Weekly Report: what happened at LFCR last week (0907-0911)?
Weekly Report · 09/14 10:05
Weekly Report: what happened at LFCR last week (0831-0904)?
Weekly Report · 09/07 09:59
Analysts Offer Insights on Healthcare Companies: Ultragenyx Pharmaceutical (RARE) and Lifecore Biomedical (LFCR)
TipRanks · 09/03 11:50
Lifecore Biomedical rises on deal with global pharma company
Seeking Alpha · 09/02 14:39
Lifecore Biomedical Adds New Commercial Program, Expands 2028 Revenue Pipeline; Stock Up
NASDAQ · 09/02 11:59
Lifecore signs agreement for commercial site transfer for pharmaceutical company
TipRanks · 09/02 11:45
Weekly Report: what happened at LFCR last week (0824-0828)?
Weekly Report · 08/31 10:05
Weekly Report: what happened at LFCR last week (0817-0821)?
Weekly Report · 08/24 10:06
Lifecore Biomedical Earnings Call Balances Growth and Strain
TipRanks · 08/22 00:22
Weekly Report: what happened at LFCR last week (0810-0814)?
Weekly Report · 08/17 10:06
Analyst Reaffirms Buy on Lifecore as Management Sticks to 2026 Targets and Pipeline-Driven Growth Outlook
TipRanks · 08/11 11:55
Weekly Report: what happened at LFCR last week (0803-0807)?
Weekly Report · 08/10 10:02
Analysts Offer Insights on Healthcare Companies: Lifecore Biomedical (LFCR), Elanco Animal Health (ELAN) and Alpha Teknova (TKNO)
TipRanks · 08/06 08:50
Analysts Are Bullish on Top Healthcare Stocks: Palvella Therapeutics (PVLA), Lifecore Biomedical (LFCR)
TipRanks · 08/05 18:00
Lifecore reports Q2 EPS (19c), consensus (22c)
TipRanks · 08/05 14:30
Lifecore backs FY26 revenue view $120M-$125M, consensus $122.18M
TipRanks · 08/05 14:30
*Lifecore Biomedical Backs 2026 Adj EBITDA of $20.5M-$25M >LFCR
Dow Jones · 08/05 11:08
*Lifecore Biomedical Backs 2026 Rev $120M-$125M >LFCR
Dow Jones · 08/05 11:07
More
Webull provides a variety of real-time LFCR stock news. You can receive the latest news about Lifecore Biomedical Inc through multiple platforms. This information may help you make smarter investment decisions.
About LFCR
Lifecore Biomedical, Inc. is a fully integrated contract development and manufacturing organization that provides services in the development, fill and finish of complex sterile injectable pharmaceutical products in syringes, vials and cartridges. It manufactures pharmaceutical-grade, non-animal-sourced hyaluronic acid (HA) using fermentation-based HA process. It manufactures HA in bulk form and for use in formulated and filled syringes and vials for our customers’ injectable products used in treating medical conditions and procedures, including ophthalmic and orthopedic applications. Its product development service capabilities include analytical method development and validation, formulation development, sterile filtration, process scale-up, pilot studies, stability studies, process validation and production of materials for clinical studies. It also operates semi-automated restricted access barrier systems (RABS) and fully automated aseptic filling lines with isolators.